Department of Medicine I, Gastroenterology, Hepatology and Endocrinology, Medical University of Innsbruck, Innsbruck, Austria.
Centre for Disease Analysis (CDA), Lafayette, Colorado, United States of America.
PLoS One. 2018 Jul 12;13(7):e0200750. doi: 10.1371/journal.pone.0200750. eCollection 2018.
In 2016, the World Health Organization (WHO) and 69th World Health Assembly approved the first global health sector strategy (GHSS) on viral hepatitis with the goal to eliminate hepatitis C virus (HCV) infections worldwide. The aim is a 90% reduction of new infections and 65% reduction of HCV-related deaths by 2030.
This study reports on the epidemiology of HCV infections in the Austrian state of Tyrol (total population 750,000) and uses a predictive model to identify how the WHO strategy for elimination of HCV can be achieved.
We developed a regional disease burden model based on observed local diagnosis data from 2001 to 2016. Scenarios were developed to evaluate the impact of diagnosis and treatment on HCV-related outcomes (viremic prevalence, decompensated cirrhosis, hepatocellular carcinoma, and liver-related deaths) from 2015 through 2030.
In the last 15 years, 1,721 patients living in Tyrol have been diagnosed with chronic HCV infection. When ageing, mortality and treatment were factored in, there were an estimated 2,043 viremic HCV infections in 2016, of which 1,136 cases had been diagnosed. A baseline model predicts a decrease of 588 HCV cases from 2015 to 2030, which would not translate into the significant reduction of infections needed to achieve WHO global health recommendations. A total of 1,843 infected individuals need to be identified and treated to achieve the WHO goals by 2030 (1,254 averted cases as compared to baseline model). Implementation of this strategy would avoid 523 new HCV infections and decreases HCV-related mortality by 73%.
HCV elimination and >65% reduction of associated mortality are possible for Tyrol, but requires a significant increase in new diagnoses and treatment rate. The model presented in this study could serve as an example for other regions to reliably predict regional disease burden and estimate how WHO goals can be met in the future.
2016 年,世界卫生组织(WHO)和第 69 届世界卫生大会批准了首个全球卫生部门病毒性肝炎战略(GHSS),目标是在全球消除丙型肝炎病毒(HCV)感染。目标是到 2030 年将新感染率降低 90%,将 HCV 相关死亡率降低 65%。
本研究报告了奥地利蒂罗尔州(总人口 75 万)HCV 感染的流行病学情况,并使用预测模型来确定如何实现消除 HCV 的世卫组织战略。
我们根据 2001 年至 2016 年的当地诊断数据开发了一个区域疾病负担模型。制定了方案来评估诊断和治疗对 HCV 相关结果(病毒血症流行率、失代偿性肝硬化、肝细胞癌和与肝脏相关的死亡)的影响,时间跨度为 2015 年至 2030 年。
在过去的 15 年中,有 1721 名居住在蒂罗尔州的患者被诊断患有慢性 HCV 感染。考虑到年龄、死亡率和治疗因素,2016 年估计有 2043 例 HCV 病毒血症感染,其中 1136 例已确诊。基线模型预测,2015 年至 2030 年 HCV 病例将减少 588 例,但这不会转化为显著减少感染,以实现世卫组织全球卫生建议。到 2030 年,需要发现和治疗总共 1843 名感染者,以实现世卫组织的目标(与基线模型相比,避免 523 例新 HCV 感染和减少 73%的 HCV 相关死亡率)。
对于蒂罗尔州来说,消除 HCV 和将相关死亡率降低 >65%是可能的,但需要大幅提高新诊断和治疗率。本研究中提出的模型可以作为其他地区的范例,以可靠地预测区域疾病负担,并估计未来如何实现世卫组织的目标。